Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience-Reference-Cited by-同舟云学术

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience

Published:2012-08 Issue:8 Volume:23 Page:1963-1967
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Wheler J.J.,Tsimberidou A.M.,Hong D.S.,Naing A.,Falchook G.S.,Fu S.,Moulder S.,Stephen B.,Wen S.,Kurzrock R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/8/1963/13788564/mds027.pdf

Reference23 articles.

1. American Cancer Society: Cancer Facts & Figures 2011,2011

2. Risks and benefits of phase 1 oncology trials, 1991 through 2002;Horstmann;N Engl J Med,2005

3. Risks and benefits of phase 1 oncology trials, revisited;Kurzrock;N Engl J Med,2005

4. Therapeutic response and potential pitfalls in phase I clinical trials of anticancer agents conducted in Japan;Itoh;Cancer Chemother Pharmacol,1994

5. Therapeutic response in phase I trials of antineoplastic agents;Estey;Cancer Treat Rep,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Insights on Selective and Specific Inhibitors of Cyclin Dependent Kinase 9 Enzyme (CDK9) for the Purpose of Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-02

2. Glycogen synthase kinase-3β inhibitors as a novel promising target in the treatment of cancer: Medicinal chemistry perspective;Results in Chemistry;2022-01

3. First-In-Human Phase 1 Clinical Trials – A Single-Center Experience In The Era Of Modern Oncotherapeutics;Scientific Reports;2020-05-13

4. Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity;Nature Communications;2019-05-03

5. Ethical issues in the care of adolescent and young adult oncology patients;Pediatric Blood & Cancer;2019-01-08